Japan Medical Cannabis Market, by Derivative

Growth Outlook

• The Japan Medical Cannabis Market, by Derivative market is on a steady long-term growth path. Segment value stands at roughly USD 2 Mn in 2026 and is projected to reach USD 3 Mn by 2027 — a gain of about 29% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Cannabidiol leads, holding roughly 72% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
• By 2027, Cannabidiol alone is expected to reach USD 2 Mn, with Tetrahydrocannabinol at USD 1 Mn.

Market Dynamics

Japan is renowned for its advanced medical technology and high-quality healthcare system. However, one area that has been largely overlooked in Japan is the use of medical cannabis. Despite being one of the most technologically advanced countries in the world, Japan has yet to fully embrace the potential benefits of medical cannabis. This has led to a growing demand for the legalization and regulation of medical cannabis in the country.

One of the driving forces behind the demand for medical cannabis in Japan is the potential for its use as a treatment option for various medical conditions. Medical cannabis has been shown to be effective in managing chronic pain, reducing anxiety and improving sleep, among other things. With an aging population and an increase in chronic ailments, there is a need for alternative treatment options in Japan. This is where medical cannabis comes in, offering potential relief for those suffering from these conditions.

Another factor contributing to the demand for medical cannabis in Japan is the increasing global acceptance and recognition of its therapeutic benefits. Many countries and states around the world have legalized medical cannabis, and the results have been overwhelmingly positive. This has led to a shift in attitudes towards medical cannabis, with more people recognizing its potential benefits and calling for its legalization in Japan.

The demand for medical cannabis in Japan is not limited to its use as a whole plant. There is also a growing demand for different derivatives of medical cannabis, such as oils, tinctures, and topicals. These derivatives offer a more precise and controlled way of administering medical cannabis, making it a more attractive option for medical professionals and patients alike. Additionally, these derivatives have a lower risk of abuse and addiction, making them a more socially acceptable option in Japan.

Furthermore, the demand for medical cannabis derivatives is also driven by the potential economic benefits they offer. As the global demand for medical cannabis grows, many countries are reaping the economic benefits from its production and sale. Japan is no exception, and there is a growing demand from businesses and investors for the legalization of medical cannabis so that they can tap into this growing market.

In conclusion, the demand for medical cannabis in Japan is driven by the potential health benefits, global recognition, and economic gains it can offer. With more research being conducted on medical cannabis and its derivatives, it is only a matter of time before Japan catches up with the rest of the world in embracing this potential treatment option.